Disclosure Of Interests In Other Entities [Text Block]

Bayer AG - Filing #6464694

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
Disclosure of interests in other entities [text block]
5
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Der Konsolidierungskreis entwickelte sich im Geschäftsjahr 2024 wie folgt:
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests
6,000,000 EUR
1,000,000 EUR
Non-controlling interests
137,000,000 EUR
151,000,000 EUR
Current assets
34,444,000 EUR
37,556,000 EUR
Non-current assets
76,406,000 EUR
78,703,000 EUR
Current liabilities
28,952,000 EUR
29,457,000 EUR
Non-current liabilities
49,853,000 EUR
53,724,000 EUR
Revenue
46,606,000 EUR
47,637,000 EUR
Profit (loss)
6,000,000 EUR
2,546,000 EUR
2,552,000 EUR
2,552,000 EUR
2,942,000 EUR
1,000,000 EUR
2,941,000 EUR
2,941,000 EUR
Comprehensive income
949,000,000 EUR
3,427,000 EUR
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Profit (loss) from continuing operations
2,546,000 EUR
2,942,000 EUR
Other comprehensive income
3,000,000 EUR
1,597,000 EUR
75,000,000 EUR
86,000,000 EUR
1,385,000 EUR
370,000,000 EUR
1,594,000 EUR
659,000,000 EUR
485,000,000 EUR
27,000,000 EUR
2,000,000 EUR
123,000,000 EUR
326,000,000 EUR
483,000,000 EUR
Investments accounted for using equity method
820,000,000 EUR
850,000,000 EUR
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Zusätzlich wurden Anteile an 43 assoziierten Unternehmen (Vorjahr: 42) sowie vier Gemeinschaftsunternehmen (Vorjahr: vier) im Konzernabschluss nach der Equity-Methode bilanziert. Diese sind in Anhangan-gabe [16] erläutert.
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
6,191,000 EUR
5,907,000 EUR
5,171,000 EUR
Other current financial liabilities
5,313,000 EUR
6,830,000 EUR
Other non-current financial liabilities
35,498,000 EUR
38,176,000 EUR
Tax expense (income)
212,000,000 EUR
1,321,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.